Literature DB >> 12409468

Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.

Shiro Koizume1, Ken Tachibana, Takao Sekiya, Setsuo Hirohashi, Masahiko Shiraishi.   

Abstract

The structural alteration of chromatin has a key role in regulating gene expression. The alteration of chromatin is mediated by modification of its components. Detailed understanding of the relationship between these modifications, notably, methylation of the full-length CpG island, the association of methyl-CpG binding proteins (MBPs), and the acetylation and methylation of histones in gene silencing is vitally important. Currently, however, the manner in which chromatin components, associated with a specific gene, are modified is poorly understood. Here we provide in vivo evidence in cancer cells of the differential association between CpG methylation, MBPs, and histone modification in the entire CpG island of the human E-cadherin (CDH1) gene. Of the cell lines with CDH1 transcriptional repression, the distribution of methyl-CpGs in the CpG island differed markedly. In a cell line with gene silencing, the promoter region was almost methylation-free. Chromatin immunoprecipitation analysis revealed that the acetylation status of histone H4 differed between cell lines. However, deacetylated histone H3 was associated with the CpG island in all silenced cell lines. Binding of MeCP2 was also detected in all silenced cell lines. Additional binding of MBD1 protein was detected in a cell line in which the promoter region was poorly methylated and only histone H3 was deacetylated. Binding of MBD2 protein was detected in all other silenced cell lines. Histone H3 lysine 9 was methylated in all silenced cells, while histone H3 lysine 4 was methylated in some silenced cell lines. These results demonstrate that chromatin components associated with inactive CDH1 chromatin is heterogeneously modified and suggests the presence of multiple pathways for the formation of inactive chromatin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409468      PMCID: PMC135805          DOI: 10.1093/nar/gkf593

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  51 in total

1.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.

Authors:  Y Zhang; H H Ng; H Erdjument-Bromage; P Tempst; A Bird; D Reinberg
Journal:  Genes Dev       Date:  1999-08-01       Impact factor: 11.361

2.  MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery.

Authors:  N K Kaludov; A P Wolffe
Journal:  Nucleic Acids Res       Date:  2000-05-01       Impact factor: 16.971

3.  Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.

Authors:  M C Lorincz; D Schübeler; M Groudine
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 4.  Histone methylation in transcriptional control.

Authors:  Tony Kouzarides
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

5.  The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.

Authors:  E Batlle; E Sancho; C Francí; D Domínguez; M Monfar; J Baulida; A García De Herreros
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

6.  Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.

Authors:  C T Nguyen; F A Gonzales; P A Jones
Journal:  Nucleic Acids Res       Date:  2001-11-15       Impact factor: 16.971

7.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

8.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex.

Authors:  H H Ng; Y Zhang; B Hendrich; C A Johnson; B M Turner; H Erdjument-Bromage; P Tempst; D Reinberg; A Bird
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

9.  Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase.

Authors:  H Wang; R Cao; L Xia; H Erdjument-Bromage; C Borchers; P Tempst; Y Zhang
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

10.  Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.

Authors:  B Coffee; F Zhang; S T Warren; D Reines
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

View more
  14 in total

Review 1.  Involvement of members of the cadherin superfamily in cancer.

Authors:  Geert Berx; Frans van Roy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09-23       Impact factor: 10.005

Review 2.  Epigenetic regulation of epithelial-mesenchymal transition.

Authors:  Lidong Sun; Jia Fang
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

3.  Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion.

Authors:  Kenji Kokura; Lidong Sun; Mark T Bedford; Jia Fang
Journal:  EMBO J       Date:  2010-09-24       Impact factor: 11.598

Review 4.  Epigenetic alterations involved in cancer stem cell reprogramming.

Authors:  Purificación Muñoz; Maria S Iliou; Manel Esteller
Journal:  Mol Oncol       Date:  2012-10-26       Impact factor: 6.603

Review 5.  DNA methylation in pulmonary fibrosis and lung cancer.

Authors:  Juan Duan; Baiyun Zhong; Zhihua Fan; Hao Zhang; Mengmeng Xu; Xiangyu Zhang; Yan Y Sanders
Journal:  Expert Rev Respir Med       Date:  2022-06-08       Impact factor: 4.300

6.  Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis.

Authors:  Weijie Yuan; Zhikang Chen; Shaobin Wu; Jie Ge; Shi Chang; Xianwei Wang; Jingxiang Chen; Zihua Chen
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

7.  Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.

Authors:  Esteban Ballestar; Maria F Paz; Laura Valle; Susan Wei; Mario F Fraga; Jesus Espada; Juan Cruz Cigudosa; Tim Hui-Ming Huang; Manel Esteller
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

8.  The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.

Authors:  Esteban Ballestar; Santiago Ropero; Miguel Alaminos; Judith Armstrong; Fernando Setien; Ruben Agrelo; Mario F Fraga; Michel Herranz; Sonia Avila; Mercedes Pineda; Eugenia Monros; Manel Esteller
Journal:  Hum Genet       Date:  2004-11-11       Impact factor: 4.132

Review 9.  Wnt-cadherin connections in normal and neoplastic mammary epithelium.

Authors:  Valerie Meniel; Alan R Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

10.  Promoter methylation in head and neck squamous cell carcinoma cell lines is significantly different than methylation in primary tumors and xenografts.

Authors:  Patrick T Hennessey; Michael F Ochs; Wojciech W Mydlarz; Wayne Hsueh; Leslie Cope; Wayne Yu; Joseph A Califano
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.